New drug hope for deadly brain cancer: troriluzole tested before surgery
Disease control
Recruiting now
This early-phase trial tests whether the drug troriluzole can affect brain activity and reduce harmful glutamate levels in people with recurrent glioblastoma, an aggressive brain cancer. About 27 adults whose tumor has returned after standard treatment will receive the drug befor…
Phase: EARLY_PHASE1 • Sponsor: Ugonma Chukwueke • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC